CLINICAL_TRIALS
trial_result
· 2021-10-20
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone [Phase 3]
Summary
Phase 3 trial update for tirzepatide in adults with type 2 diabetes not controlled by diet and exercise, completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2021-10-20